Sign in Subscribe
Genetic research

Candida albicans Research Reveals Genetic Diversity and Antifungal Resistance Patterns

Strategic Insights

— 1 min read

Fresh data on Candida albicans have been presented in a new report, highlighting the complexity of this fungal infection and its treatment challenges. Candida albicans is a common cause of vulvovaginal candidiasis (VVC), particularly in recurrent cases, and antifungal resistance poses a significant threat to effective treatment. The study investigated the genetic diversity and antifungal resistance patterns of C. albicans isolated from VVC patients in Indian women. The results demonstrate significant genetic variability among C. albicans isolates and widespread antifungal resistance, particularly to azole-based treatments.

Key Takeaways:

  • The study analyzed 170 vaginal swab samples from Indian women, identifying 122 Candida isolates, with 35 confirmed as C. albicans.
  • Antifungal susceptibility tests revealed that Nystatin showed the highest sensitivity (60%), followed by miconazole (54.29%) and fluconazole (42.86%).
  • Itraconazole and clotrimazole also showed considerable resistance at 51.43% and 48.57%, respectively. Amphotericin B demonstrated moderate efficacy, with 20% sensitivity and a high intermediate response (45.71%).
  • Genetic diversity analysis using ISSR and RAPD markers showed considerable polymorphism, indicating a heterogeneous C. albicans population.
  • Strain S95 exhibited significant genetic divergence compared to other isolates, suggesting unique genetic characteristics.
  • The study concluded that the results underscore the importance of regular monitoring of genetic diversity and resistance patterns in C. albicans to guide effective treatment strategies for VVC.
  • The study was conducted by researchers from Siksha 'O' Anusandhan (Deemed to be University) and co-authored by Binaya Krushna Sahu, Utkalika Mallick, Rashmi Hegde, Jyotirmayee Turuk, Mahesh Chandra Sahu, and Sujogya Kumar Panda.

Statistics:

  • 170 vaginal swab samples were collected from Indian women attending obstetrics and gynecology departments.
  • 122 Candida isolates were identified, with 35 confirmed as C. albicans.
  • 18 representative C. albicans isolates were analyzed for genetic diversity.
  • Antifungal susceptibility tests revealed the following sensitivity rates:

+ Nystatin (60%)

+ Miconazole (54.29%)

+ Fluconazole (42.86%)

+ Itraconazole (51.43% resistance)

+ Clotrimazole (48.57% resistance)

+ Amphotericin B (20% sensitivity, 45.71% intermediate response)

Sources:

  • Genetic diversity and antifungal resistance in Candida albicans from VVC cases in Indian women. BMC Microbiology, 2025,25(1):1-12. (BMC Microbiology - http://www.biomedcentral.com/bmcmicrobiol/)
  • Siksha 'O' Anusandhan (Deemed to be University)
  • NewsRx. Studies from Siksha 'O' Anusandhan (Deemed to be University) Update Current Data on Candida albicans (Genetic diversity and antifungal resistance in Candida albicans from VVC cases in Indian women). OBGYN & Reproduction Week. September 8, 2025; p 583.

Read more